Congress Asset Management CO Neurocrine Biosciences Inc Transaction History

Congress Asset Management CO

$14.3 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$130.86 - $143.19 $373,605 - $408,807	2,855 New	2,855 $393,000
Q3 2023 Nov 01, 2023	SELL	$94.02 - $117.1 $145,072 - $180,685	-1,543 Reduced 26.73%	4,229 $475,000
Q2 2023 Jul 27, 2023	SELL	$89.53 - $104.87 $81.9 Million - $95.9 Million	-914,281 Reduced 99.37%	5,772 $544,000
Q1 2023 Apr 21, 2023	BUY	$94.11 - $123.02 $209,677 - $274,088	2,228 Added 0.24%	920,053 $93.1 Million
Q4 2022 Jan 18, 2023	SELL	$106.72 - $127.06 $18.8 Million - $22.4 Million	-176,352 Reduced 16.12%	917,825 $0
Q3 2022 Nov 08, 2022	BUY	$92.03 - $107.81 $1.87 Million - $2.19 Million	20,335 Added 1.89%	1,094,177 $116 Million
Q2 2022 Aug 02, 2022	SELL	$75.79 - $100.07 $2.8 Million - $3.7 Million	-37,006 Reduced 3.33%	1,073,842 $105 Million
Q1 2022 Apr 20, 2022	BUY	$72.45 - $94.81 $14.6 Million - $19.1 Million	201,760 Added 22.19%	1,110,848 $104 Million
Q4 2021 Jan 28, 2022	SELL	$79.65 - $106.22 $8.18 Million - $10.9 Million	-102,684 Reduced 10.15%	909,088 $77.4 Million
Q3 2021 Nov 08, 2021	BUY	$86.18 - $99.03 $5.45 Million - $6.26 Million	63,207 Added 6.66%	1,011,772 $97 Million
Q2 2021 Aug 05, 2021	BUY	$89.43 - $102.27 $4.18 Million - $4.78 Million	46,731 Added 5.18%	948,565 $92.3 Million
Q1 2021 May 05, 2021	BUY	$87.57 - $119.4 $12.3 Million - $16.8 Million	140,893 Added 18.52%	901,834 $87.7 Million
Q4 2020 Jan 26, 2021	SELL	$86.91 - $108.33 $583,079 - $726,785	-6,709 Reduced 0.87%	760,941 $72.9 Million
Q3 2020 Nov 03, 2020	BUY	$96.16 - $135.15 $73.8 Million - $104 Million	767,650 New	767,650 $73.8 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.92 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.35 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$697 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$349 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$252 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account